The ION-Ghent guidelines for the management of immune related adverse events (irAE's)
- Author
- Vibeke Kruse (UGent) , Max Schreuer (UGent) , Karim Vermaelen (UGent) , Piet Ost (UGent) , Tessa Kerre (UGent) , Barbara De Moerloose (UGent) and Lieve Brochez (UGent)
- Organization
Downloads
-
(...).pdf
- full text
- |
- UGent only
- |
- |
- 1.61 MB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-8554892
- MLA
- Kruse, Vibeke, et al. “The ION-Ghent Guidelines for the Management of Immune Related Adverse Events (IrAE’s).” BELGIAN JOURNAL OF MEDICAL ONCOLOGY, vol. 11, no. 6, 2017, pp. 265–75.
- APA
- Kruse, V., Schreuer, M., Vermaelen, K., Ost, P., Kerre, T., De Moerloose, B., & Brochez, L. (2017). The ION-Ghent guidelines for the management of immune related adverse events (irAE’s). BELGIAN JOURNAL OF MEDICAL ONCOLOGY, 11(6), 265–275.
- Chicago author-date
- Kruse, Vibeke, Max Schreuer, Karim Vermaelen, Piet Ost, Tessa Kerre, Barbara De Moerloose, and Lieve Brochez. 2017. “The ION-Ghent Guidelines for the Management of Immune Related Adverse Events (IrAE’s).” BELGIAN JOURNAL OF MEDICAL ONCOLOGY 11 (6): 265–75.
- Chicago author-date (all authors)
- Kruse, Vibeke, Max Schreuer, Karim Vermaelen, Piet Ost, Tessa Kerre, Barbara De Moerloose, and Lieve Brochez. 2017. “The ION-Ghent Guidelines for the Management of Immune Related Adverse Events (IrAE’s).” BELGIAN JOURNAL OF MEDICAL ONCOLOGY 11 (6): 265–275.
- Vancouver
- 1.Kruse V, Schreuer M, Vermaelen K, Ost P, Kerre T, De Moerloose B, et al. The ION-Ghent guidelines for the management of immune related adverse events (irAE’s). BELGIAN JOURNAL OF MEDICAL ONCOLOGY. 2017;11(6):265–75.
- IEEE
- [1]V. Kruse et al., “The ION-Ghent guidelines for the management of immune related adverse events (irAE’s),” BELGIAN JOURNAL OF MEDICAL ONCOLOGY, vol. 11, no. 6, pp. 265–275, 2017.
@article{8554892, author = {{Kruse, Vibeke and Schreuer, Max and Vermaelen, Karim and Ost, Piet and Kerre, Tessa and De Moerloose, Barbara and Brochez, Lieve}}, issn = {{1784-7141}}, journal = {{BELGIAN JOURNAL OF MEDICAL ONCOLOGY}}, language = {{eng}}, number = {{6}}, pages = {{265--275}}, title = {{The ION-Ghent guidelines for the management of immune related adverse events (irAE's)}}, volume = {{11}}, year = {{2017}}, }